ShanXi C&Y Pharmaceutical Group Co.,LTD. (SHE:300254)

SHE:300254 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Net Income	36.19	24.85	42.19	25.2	-118.52	-91.44
Depreciation & Amortization	59.53	58.41	58.25	58.53	64.79	66.93
Other Amortization	4.27	2.95	1.02	0.85	0.75	0.74
Loss (Gain) From Sale of Assets	-1.05	-8.94	-7.51	-18.8	-0.69	0.37
Asset Writedown & Restructuring Costs	1.46	0.43	5.67	5.51	48.4	31.68
Loss (Gain) From Sale of Investments	-0.88	-3.97	-4.54	-20.88	3.43	-13.64
Provision & Write-off of Bad Debts	5.6	5.08	5.78	-0.43	0.71	-5.32
Other Operating Activities	61.4	76.56	52.64	56.12	68.93	73.92
Change in Accounts Receivable	50.34	-40.67	-71.14	-5.35	-120.83	119.48
Change in Inventory	-27.71	-2.3	-28.39	-20.61	3.81	6.31
Change in Accounts Payable	-61.26	-36.67	13.4	-40.02	123.41	-91.56
Change in Other Net Operating Assets	35.11	24.17	13.48	-	-	-
Operating Cash Flow	155.36	96.77	70.94	37.81	74.88	96.92
Operating Cash Flow Growth	371.49%	36.41%	87.60%	-49.50%	-22.75%	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Capital Expenditures	-29.36	-34.32	-51.5	-33.92	-26.78	-36.93
Sale of Property, Plant & Equipment	0.51	0.35	0.21	100.83	2.12	6.42
Divestitures	-	-	1.63	-	-	-0.27
Investment in Securities	-	-60.29	-202.84	5.19	1.47	5.57
Other Investing Activities	-9.92	2.36	4.23	-	-	-
Investing Cash Flow	-38.77	-91.89	-248.27	72.1	-23.2	-25.21

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Short-Term Debt Issued	-	-	1.8	-	-	-
Long-Term Debt Issued	-	286.3	321.62	115.75	271.6	100.9
Total Debt Issued	325.8	286.3	323.42	115.75	271.6	100.9
Short-Term Debt Repaid	-	-	-1.8	-	-	-
Long-Term Debt Repaid	-	-305.08	-144.7	-138.74	-223.42	-218.32
Lease Payments	-5.41	-10.06	-5.73	-3.49	-	-5.41
Total Debt Repaid	-283.96	-305.08	-146.5	-138.74	-223.42	-218.32
Net Debt Issued (Repaid)	41.84	-18.78	176.93	-22.99	48.18	-117.42
Issuance of Common Stock	50.68	43.96	33.35	-	105.25	-
Repurchase of Common Stock	-0.29	-0.29	-1.66	-203.24	-	-
Common Dividends Paid	-17.61	-18.97	-12.32	-13.31	-11.9	-14.67
Other Financing Activities	-186.83	1	-1.45	-2.23	-28.96	-20.21
Financing Cash Flow	-112.22	6.93	194.84	-241.77	112.56	-152.3

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Net Cash Flow	4.37	11.8	17.51	-131.85	164.24	-80.58

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Free Cash Flow	126	62.45	19.44	3.9	48.09	59.99
Free Cash Flow Growth	915.30%	221.25%	398.72%	-91.90%	-19.84%	-
Free Cash Flow Margin	14.83%	7.17%	2.30%	0.49%	5.80%	6.45%
Free Cash Flow Per Share	0.51	0.26	0.08	0.02	0.20	0.26
Levered Free Cash Flow	118.57	170.49	-82.9	-157.05	316.58	23.16
Unlevered Free Cash Flow	124.64	184.01	-72.29	-136.33	345.37	53.89
Free Cash Flow After Leases	120.59	52.39	13.71	0.41	48.09	54.58

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash Income Tax Paid	117.19	125.29	96.53	116.45	89.17	89.28
Change in Working Capital	-11.15	-58.59	-82.56	-68.28	7.07	33.67

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error